Inhaled corticosteroids for outpatients with COVID-19: a meta-analysis
Todd C. Lee, Émilie Bortolussi‐Courval, Sara Belga, Nick Daneman, Adrienne K. Chan, Ryan Hanula, Nicole Ezer, Emily G. McDonald
Abstract
<b>The role of inhaled corticosteroids for outpatient COVID-19 is evolving. Meta-analysis of reported clinical trials estimated probability of any effect for symptom resolution by day 14 at 100% and hospitalisation at 89.3%, respectively.</b>https://bit.ly/3B2sDUi
Topics & Concepts
MedicineMeta-analysisCoronavirus disease 2019 (COVID-19)Inhaled corticosteroidsSevere acute respiratory syndrome coronavirus 2 (SARS-CoV-2)2019-20 coronavirus outbreakInternal medicineVirologyAsthmaInfectious disease (medical specialty)OutbreakDiseaseLong-Term Effects of COVID-19COVID-19 Clinical Research StudiesThermal Regulation in Medicine